Stephen A. Black
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephen A. Black has a total of 293 co-authors. Here are the top co-authors by number of shared publications:
- Prakash Saha
Department of Vascular Surgery, St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
10 shared publications Alberto Smith
School of Cardiovascular Medicine and Sciences, King's College London, UK
7 shared publicationsBelen Quintana
Department of Vascular Surgery, Guy’s and St Thomas’ Hospital , London , UK
6 shared publications- Adam M. Gwozdz
Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK
5 shared publications Karen Breen
Guy's and St Thomas' NHS Foundation Trust, London, UK
5 shared publicationsPrakash Saha
5 shared publications
Latest Publications
- Open Access
- 1 November 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (11) , e018175
Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans
BACKGROUND: Randomized trials of venous thrombolysis to prevent postthrombotic syndrome have produced mixed results. A method to identify patients most likely to benefit from interventional treatment is needed. This study evaluated a contrast-free, magnetic resonance-based multisequence thrombus imaging (MSTI) technique to characterize deep venous thrombi and predict susceptibility to thrombolysis. METHODS: Venous thrombosis was induced in the inferior vena cava of BALB/C mice (n=56, male), which were imaged up to 28 days postsurgery and 24 hours after systemic thrombolysis (Actilyse, 10 mg/kg, IV). The prelysis MSTI protocol included 3-dimensional T1 mapping, 3-dimensional magnetization transfer, and 2-dimensional diffusion-weighted imaging. Thrombolysis was defined as successful if inferior vena cava blood flow increased by ≥50% compared with prelysis values. In a clinical cohort, 41 patients with acute iliofemoral deep venous thrombi underwent MSTI before catheter-directed thrombolysis. Imaging parameters were analyzed against postintervention outcomes. RESULTS: MSTI identified thrombi susceptible to thrombolysis in both mice and humans. In mice, lysed thrombi showed lower T1 (723 [667–782] versus 874 [799–1000] ms; P - ³ mm²/s; P P - ³ mm²/s; P =0.001), and similar magnetization transfer rates. Combining MSTI parameters optimized prediction, achieving 88% sensitivity and 97% specificity in mice, and 86% sensitivity and 91% specificity in humans. CONCLUSIONS: MSTI enables noninvasive, contrast-free characterization of thrombus composition and predicts thrombolytic susceptibility. This technique has the potential to guide patient selection for invasive therapies and should be incorporated into future trials of venous thrombosis treatment.
- 1 November 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (11) , e018175
Open AccessMultiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans
BACKGROUND: Randomized trials of venous thrombolysis to prevent postthrombotic syndrome have produced mixed results. A method to identify patients most likely to benefit from interventional treatment is needed. This study evaluated a contrast-free, magnetic resonance-based multisequence thrombus imaging (MSTI) technique to characterize deep venous thrombi and predict susceptibility to thrombolysis. METHODS: Venous thrombosis was induced in the inferior vena cava of BALB/C mice (n=56, male), which were imaged up to 28 days postsurgery and 24 hours after systemic thrombolysis (Actilyse, 10 mg/kg, IV). The prelysis MSTI protocol included 3-dimensional T1 mapping, 3-dimensional magnetization transfer, and 2-dimensional diffusion-weighted imaging. Thrombolysis was defined as successful if inferior vena cava blood flow increased by ≥50% compared with prelysis values. In a clinical cohort, 41 patients with acute iliofemoral deep venous thrombi underwent MSTI before catheter-directed thrombolysis. Imaging parameters were analyzed against postintervention outcomes. RESULTS: MSTI identified thrombi susceptible to thrombolysis in both mice and humans. In mice, lysed thrombi showed lower T1 (723 [667–782] versus 874 [799–1000] ms; P - ³ mm²/s; P P - ³ mm²/s; P =0.001), and similar magnetization transfer rates. Combining MSTI parameters optimized prediction, achieving 88% sensitivity and 97% specificity in mice, and 86% sensitivity and 91% specificity in humans. CONCLUSIONS: MSTI enables noninvasive, contrast-free characterization of thrombus composition and predicts thrombolytic susceptibility. This technique has the potential to guide patient selection for invasive therapies and should be incorporated into future trials of venous thrombosis treatment.
- 16 September 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (3) , 475-482
Cost Effectiveness of Mechanical Thrombectomy Versus Anticoagulation for Treating Iliofemoral Deep Vein Thrombosis in the UK
- 16 September 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (3) , 475-482
Cost Effectiveness of Mechanical Thrombectomy Versus Anticoagulation for Treating Iliofemoral Deep Vein Thrombosis in the UK
- Open Access
- 27 May 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 283 (2) , 225-233
A Systematic Review and Meta-analysis of the Efficacy and Safety of Lytic and Non-lytic Early Thrombus Removal Technologies for Iliofemoral Deep Vein Thrombosis
Objectives: This systematic review and meta-analysis compared the effectiveness and safety of lytic and non-lytic early thrombus removal strategies in addition to anticoagulation versus anticoagulation alone. Background: Early thrombus removal strategies have been developed to prevent post-thrombotic syndrome (PTS) following acute iliofemoral deep vein thrombosis (DVT). Methods: This review followed PRISMA guidelines using a registered protocol (CRD42023437158). The MEDLINE and Embase databases, as well as trial registries, were searched without limitations. Head-to-head or single-armed trials or studies that reported the rate of PTS in patients with iliofemoral DVT (symptomatic for <28 days) and early thrombus removal were included. The rates of PTS, moderate-severe PTS, major bleeding, risk-benefit ratio, DVT recurrence, and mortality were pooled in meta-analysis with fixed or random effects. Results: Across all study designs (20 studies), the rate of PTS was 24.5% (95% CI: 19.5–30.3%) for lytic therapies, 18.8% (1 study) for non-lytic therapy, and 40.4% (95% CI: 35.3–45.7) for anticoagulation alone. The number needed to treat was 6 for PTS and 15 for moderate-severe PTS. In randomized trials, the odds of major bleeding with lytic therapies were 4.9 (95% CI: 1.3–19.1) compared with anticoagulation; the number needed to harm was 33. There was no major bleeding for mechanical thrombectomy. Conclusions: Early thrombus removal reduces PTS and moderate-severe PTS, while increasing nonfatal major bleeding. Mechanical thrombectomy removes major bleeding risk, but efficacy evidence is limited to 1 observational study.
- 27 May 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 283 (2) , 225-233
Open AccessA Systematic Review and Meta-analysis of the Efficacy and Safety of Lytic and Non-lytic Early Thrombus Removal Technologies for Iliofemoral Deep Vein Thrombosis
Objectives: This systematic review and meta-analysis compared the effectiveness and safety of lytic and non-lytic early thrombus removal strategies in addition to anticoagulation versus anticoagulation alone. Background: Early thrombus removal strategies have been developed to prevent post-thrombotic syndrome (PTS) following acute iliofemoral deep vein thrombosis (DVT). Methods: This review followed PRISMA guidelines using a registered protocol (CRD42023437158). The MEDLINE and Embase databases, as well as trial registries, were searched without limitations. Head-to-head or single-armed trials or studies that reported the rate of PTS in patients with iliofemoral DVT (symptomatic for <28 days) and early thrombus removal were included. The rates of PTS, moderate-severe PTS, major bleeding, risk-benefit ratio, DVT recurrence, and mortality were pooled in meta-analysis with fixed or random effects. Results: Across all study designs (20 studies), the rate of PTS was 24.5% (95% CI: 19.5–30.3%) for lytic therapies, 18.8% (1 study) for non-lytic therapy, and 40.4% (95% CI: 35.3–45.7) for anticoagulation alone. The number needed to treat was 6 for PTS and 15 for moderate-severe PTS. In randomized trials, the odds of major bleeding with lytic therapies were 4.9 (95% CI: 1.3–19.1) compared with anticoagulation; the number needed to harm was 33. There was no major bleeding for mechanical thrombectomy. Conclusions: Early thrombus removal reduces PTS and moderate-severe PTS, while increasing nonfatal major bleeding. Mechanical thrombectomy removes major bleeding risk, but efficacy evidence is limited to 1 observational study.
- Open Access
- 4 November 2024
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 47 (12) , 1669-1676
Complications of Deep Venous Stenting and Their Management
Complications after iliofemoral and inferior vena cava stenting are rare, and most can be managed effectively without significant long-term consequences for the patient. Nevertheless, the procedure is not without risk, and clinicians considering starting a venous practice must be aware of the range of complications that can occur, which range from minor access site bleeds to fatal arrhythmia from stent migration to the heart. Most complications can be avoided with appropriate patient selection, stent sizing, and careful access and deployment techniques.
- 4 November 2024
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 47 (12) , 1669-1676
Open AccessComplications of Deep Venous Stenting and Their Management
Complications after iliofemoral and inferior vena cava stenting are rare, and most can be managed effectively without significant long-term consequences for the patient. Nevertheless, the procedure is not without risk, and clinicians considering starting a venous practice must be aware of the range of complications that can occur, which range from minor access site bleeds to fatal arrhythmia from stent migration to the heart. Most complications can be avoided with appropriate patient selection, stent sizing, and careful access and deployment techniques.
- 30 April 2024
- Published by Springer Nature
- p. 797-801
Endovascular Treatment of Chronic Venous Disease
- 20 March 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (4) , 982
Management of Lower Extremity Venous Outflow Obstruction: Results of an International Delphi Consensus
- 20 March 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (4) , 982
Management of Lower Extremity Venous Outflow Obstruction: Results of an International Delphi Consensus
- Open Access
- 4 March 2024
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (5) , 101866
Single-session mechanical thrombectomy for iliofemoral deep vein thrombosis using a dual mechanism of action device combining basket and rotational thrombectomy
- 4 March 2024
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (5) , 101866
Open AccessSingle-session mechanical thrombectomy for iliofemoral deep vein thrombosis using a dual mechanism of action device combining basket and rotational thrombectomy
- 1 March 2024
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 65 (1) , 42-48
Randomized controlled trials of interventions for acute iliofemoral deep venous thrombosis
Article: Randomized controlled trials of interventions for acute iliofemoral deep venous thrombosis - The Journal of Cardiovascular Surgery 2024 Jan 16 - Minerva Medica - Journals
- 1 March 2024
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 65 (1) , 42-48
Randomized controlled trials of interventions for acute iliofemoral deep venous thrombosis
Article: Randomized controlled trials of interventions for acute iliofemoral deep venous thrombosis - The Journal of Cardiovascular Surgery 2024 Jan 16 - Minerva Medica - Journals